Pharma partnering solutions

Partner with PGDx from biomarker discovery to CDx


Agile development across the CDx continuum

PGDx solutions are designed to enable local oncology insights on a global scale. We bring years of experience to cutting-edge diagnostics development, with regulatory and commercialization expertise to bring your breakthrough to market.

Proven performance

Leading tissue and liquid biopsy solutions accurately highlight current and emerging biomarkers and genomic signatures, supported by industry-respected publications and key opinion leaders across the globe

Global market access

Our kitted solutions are easily distributable and compliant across multiple geographies, helping our partners access larger patient cohorts via labs around the world

Build on our established platform

De-risk operational set-up and avoid lengthy validation timelines with our FDA cleared and CE-IVD marked CGP kit


Fast-track to CDx with our established platform

Using our proven technology expedites and streamlines your CDx development process. Our comprehensive panel approach delivers robust insights from a single test, supporting both CDx markers as well as retrospective endpoints.

PGDx offers deep companion diagnostic development expertise and global biopharma partnership experience, with a demonstrated track record of navigating complicated technical and legal frameworks internationally. We leverage this knowledge to power every partnership and support your therapy development and commercialization goals.

Our joint project team and dedicated service coordinators are here to provide best-in-class customer service throughout your project. We provide flexible clinical trial set-up options via in-house testing or through our CRO network. Our team is committed to providing direct support every step of the way as you navigate the regulatory landscape to approval.

Our expertise in trial transfers and established distributed kit model ease the transition from single-site LDTs and enable global patient access. We understand the breadth of molecular diagnostic approaches and platforms, enabling you to bridge efficiently.


Solutions across the clinical development continuum

From biomarker discovery to global CDx commercialization

We provide reliable precision diagnostic solutions to help researchers and partners unlock a deeper understanding of tumor biology to drive biomarker-informed therapy development. Our kitted solutions are available worldwide and are designed to comply across global regulations.

CAP/CLIA trial enrollment

Dynamic solutions including in-house capabilities to support prospective clinical trial testing

CDx co-development

Global regulatory expertise and CDx
commercialization experience

Stay Connected
Contact Us